Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium leprae | Probable transmembrane transport protein | 0.0238 | 0.0899 | 0.1219 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1927 | 0.9831 | 0.5 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1531 | 0.7736 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1927 | 0.9831 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1927 | 0.9831 | 1 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.0983 | 0.4838 | 1 |
Wolbachia endosymbiont of Brugia malayi | 2,3,4,5-tetrahydropyridine-2,6-carboxylate N-succinyltransferase | 0.0071 | 0.0014 | 0.5 |
Echinococcus granulosus | carbonic anhydrase | 0.0763 | 0.3677 | 0.3731 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.1927 | 0.9831 | 0.9733 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1927 | 0.9831 | 0.5 |
Echinococcus granulosus | carbonic anhydrase II | 0.1927 | 0.9831 | 1 |
Leishmania major | carbonic anhydrase-like protein | 0.1927 | 0.9831 | 1 |
Echinococcus granulosus | carbonic anhydrase | 0.0763 | 0.3677 | 0.3731 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.1463 | 0.7377 | 1 |
Echinococcus granulosus | carbonic anhydrase | 0.0763 | 0.3677 | 0.3731 |
Onchocerca volvulus | Putative sulfate transporter | 0.0206 | 0.073 | 1 |
Echinococcus multilocularis | carbonic anhydrase II | 0.1927 | 0.9831 | 1 |
Wolbachia endosymbiont of Brugia malayi | N-acetylglucosamine-1-phosphate uridyltransferase | 0.0071 | 0.0014 | 0.5 |
Mycobacterium ulcerans | carbonic anhydrase | 0.1463 | 0.7377 | 0.9536 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1927 | 0.9831 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1531 | 0.7736 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0763 | 0.3677 | 0.5 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.1927 | 0.9831 | 0.5 |
Mycobacterium tuberculosis | Probable conserved transmembrane protein | 0.0238 | 0.0899 | 0.1835 |
Plasmodium falciparum | carbonic anhydrase | 0.0763 | 0.3677 | 0.5 |
Onchocerca volvulus | 0.0206 | 0.073 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.1531 | 0.7736 | 1 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.0786 | 0.3797 | 0.7843 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.1927 | 0.9831 | 0.9733 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.0915 | 0.4479 | 0.9256 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.1463 | 0.7377 | 1 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.1927 | 0.9831 | 1 |
Schistosoma mansoni | carbonic anhydrase | 0.1463 | 0.7377 | 0.6013 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 11 | Effect on S phase of the cell cycle by flow cytometry | ChEMBL. | 14552774 |
Activity (functional) | = 12 | Effect on G0-G1 phase of the cell cycle by flow cytometry | ChEMBL. | 14552774 |
Activity (functional) | = 77 | Effect on G2/M phase of the cell cycle by flow cytometry | ChEMBL. | 14552774 |
IC50 (functional) | = 0.11 uM | Inhibitory activity against K562 human chronic myelogenous leukaemia cell line using MTT assay after 5 days incubation of the compound | ChEMBL. | 14552774 |
IC50 (functional) | = 0.11 uM | Inhibitory activity against K562 human chronic myelogenous leukaemia cell line using MTT assay after 5 days incubation of the compound | ChEMBL. | 14552774 |
IC50 (binding) | > 50 uM | Concentration that cause a 50% inhibition in tubulin assembly as measured by an increase inturbidity using microtubule assembly assay | ChEMBL. | 14552774 |
IC50 (binding) | > 50 uM | Concentration that cause a 50% inhibition in tubulin assembly as measured by an increase inturbidity using microtubule assembly assay | ChEMBL. | 14552774 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 14552774 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.